Relationship between miRNA and ferroptosis in tumors.

Dai, Shang-Ming; Li, Feng-Jiao; Long, Hui-Zhi; Zhou, Zi-Wei; Luo, Hong-Yu; Xu, Shuo-Guo; Gao, Li-Chen

Dai, Shang-Ming; Li, Feng-Jiao; Long, Hui-Zhi; Zhou, Zi-Wei; Luo, Hong-Yu; Xu, Shuo-Guo; Gao, Li-Chen.

Afiliación

Dai SM; Department of Pharmacy, Cancer Institute, Phase I Clinical Trial Centre, Changsha Central Hospital Affiliated to University of South China, School of Pharmacy, University of South China, Changsha, China.
Li FJ; Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hengyang, China.
Long HZ; Department of Pharmacy, Cancer Institute, Phase I Clinical Trial Centre, Changsha Central Hospital Affiliated to University of South China, School of Pharmacy, University of South China, Changsha, China.
Zhou ZW; Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hengyang, China.
Luo HY; Department of Pharmacy, Cancer Institute, Phase I Clinical Trial Centre, Changsha Central Hospital Affiliated to University of South China, School of Pharmacy, University of South China, Changsha, China.
Xu SG; Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hengyang, China.
Gao LC; Department of Pharmacy, Cancer Institute, Phase I Clinical Trial Centre, Changsha Central Hospital Affiliated to University of South China, School of Pharmacy, University of South China, Changsha, China.

Front Pharmacol ; 13: 977062, 2022.

Article en En | MEDLINE | ID: mdl-36408273

Palabras clave

ferroptosis; invasion; mechanism; metastasis; microRNA; proliferation; sensitivity of treatment; tumor

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google